These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 7678839

  • 1. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
    Kasayama S, Saito H, Kouhara H, Sumitani S, Sato B.
    J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
    [Abstract] [Full Text] [Related]

  • 2. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
    Nonomura N, Lu J, Tanaka A, Yamanishi H, Sato B, Sonoda T, Matsumoto K.
    Cancer Res; 1990 Apr 15; 50(8):2316-21. PubMed ID: 2156616
    [Abstract] [Full Text] [Related]

  • 3. Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive Shionogi carcinoma 115.
    Kasayama S, Sumitani S, Tanaka A, Yamanishi H, Nakamura N, Matsumoto K, Sato B.
    J Cell Physiol; 1991 Aug 15; 148(2):260-6. PubMed ID: 1715343
    [Abstract] [Full Text] [Related]

  • 4. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
    Yamanishi H, Nonomura N, Tanaka A, Yasui T, Nishizawa Y, Matsumoto K, Sato B.
    Cancer Res; 1990 Oct 01; 50(19):6179-83. PubMed ID: 2169337
    [Abstract] [Full Text] [Related]

  • 5. Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium.
    Yamanishi H, Nonomura N, Tanaka A, Nishizawa Y, Terada N, Matsumoto K, Sato B.
    Cancer Res; 1991 Jun 01; 51(11):3006-10. PubMed ID: 2032238
    [Abstract] [Full Text] [Related]

  • 6. Effects of thyroid hormone on androgen- or basic fibroblast growth factor-induced proliferation of Shionogi carcinoma 115 mouse mammary carcinoma cells in serum-free culture.
    Sumitani S, Kasayama S, Hirose T, Matsumoto K, Sato B.
    Cancer Res; 1991 Aug 15; 51(16):4323-7. PubMed ID: 1868455
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
    Lu J, Nishizawa Y, Tanaka A, Nonomura N, Yamanishi H, Uchida N, Sato B, Matsumoto K.
    Cancer Res; 1989 Sep 15; 49(18):4963-7. PubMed ID: 2766270
    [Abstract] [Full Text] [Related]

  • 8. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
    Jarvis MF, Gessner GW, Martin GE, Jaye M, Ravera MW, Dionne CA.
    J Pharmacol Exp Ther; 1992 Oct 15; 263(1):253-63. PubMed ID: 1383494
    [Abstract] [Full Text] [Related]

  • 9. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
    Ruohola JK, Valve EM, Vainikka S, Alitalo K, Härkönen PL.
    Endocrinology; 1995 May 15; 136(5):2179-88. PubMed ID: 7536664
    [Abstract] [Full Text] [Related]

  • 10. Effects of androgen, fibroblast growth factors or other various growth factors on growth of Shionogi carcinoma cells in a protein-free medium.
    Tanaka A, Lu J, Yamanishi H, Nonomura N, Yasui T, Maeyama M, Nishizawa Y, Matsumoto K, Sato B.
    Anticancer Res; 1990 May 15; 10(6):1637-41. PubMed ID: 2285236
    [Abstract] [Full Text] [Related]

  • 11. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S, Nishizawa Y, Nakamura N, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1987 Jan 01; 47(1):263-8. PubMed ID: 3791211
    [Abstract] [Full Text] [Related]

  • 12. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
    Crickard K, Gross JL, Crickard U, Yoonessi M, Lele S, Herblin WF, Eidsvoog K.
    Gynecol Oncol; 1994 Nov 01; 55(2):277-84. PubMed ID: 7959296
    [Abstract] [Full Text] [Related]

  • 13. Unsaturated fatty acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth factor family proteins.
    Kasayama S, Koga M, Kouhara H, Sumitani S, Wada K, Kishimoto T, Sato B.
    Cancer Res; 1994 Dec 15; 54(24):6441-5. PubMed ID: 7987840
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
    Wieder R, Fenig E, Wang H, Wang Q, Paglin S, Menzel T, Gabrilove J, Fuks Z, Yahalom J.
    J Cell Physiol; 1998 Dec 15; 177(3):411-25. PubMed ID: 9808150
    [Abstract] [Full Text] [Related]

  • 15. A role for heparan sulfate in androgen-induced deoxyribonucleic acid synthesis of mouse mammary carcinoma (Shionogi carcinoma 115)-derived SC-3 cells.
    Sumitani S, Kasayama S, Sato B.
    Endocrinology; 1993 Mar 15; 132(3):1199-206. PubMed ID: 8440181
    [Abstract] [Full Text] [Related]

  • 16. Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2).
    Furuya Y, Sato N, Akakura K, Ichikawa T, Suzuki N, Sato R, Shimazaki J.
    Cancer Res; 1990 Aug 15; 50(16):4979-83. PubMed ID: 2379162
    [Abstract] [Full Text] [Related]

  • 17. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system].
    Koga M, Kouhara H, Sato B.
    Hum Cell; 1993 Sep 15; 6(3):176-81. PubMed ID: 8297813
    [Abstract] [Full Text] [Related]

  • 18. Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cells.
    Moscatelli D.
    J Cell Physiol; 1994 Sep 15; 160(3):555-62. PubMed ID: 8077293
    [Abstract] [Full Text] [Related]

  • 19. Methylcobalamin decreases mRNA levels of androgen-induced growth factor in androgen-dependent Shionogi carcinoma 115 cells.
    Nishizawa Y, Yamamoto T, Tanigaki Y, Kasugai T, Mano M, Ishiguro S, Fushiki S, Poirier LA, Nishizawa Y.
    Nutr Cancer; 1999 Sep 15; 35(2):195-201. PubMed ID: 10693175
    [Abstract] [Full Text] [Related]

  • 20. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
    Wellstein A, Lupu R, Zugmaier G, Flamm SL, Cheville AL, Delli Bovi P, Basilico C, Lippman ME, Kern FG.
    Cell Growth Differ; 1990 Feb 15; 1(2):63-71. PubMed ID: 1964794
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.